HEADER ANTIVIRAL PROTEIN 02-OCT-12 2LZI TITLE HIGH RESOLUTION NMR STRUCTURE OF THE THETA-DEFENSIN HTD-2 (RETROCYCLIN TITLE 2 2) COMPND MOL_ID: 1; COMPND 2 MOLECULE: RETROCYCLIN 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HTD-2; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: SOLID PHASE PEPTIDE SYNTHESIS KEYWDS THETA-DEFENSIN, CYCLIC PEPTIDES, CYCLIC CYSTINE LADDER, ANTIVIRAL KEYWDS 2 PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR A.C.CONIBEAR,K.ROSENGREN,P.J.HARVEY,D.J.CRAIK REVDAT 2 19-MAR-14 2LZI 1 JRNL REVDAT 1 28-NOV-12 2LZI 0 JRNL AUTH A.C.CONIBEAR,K.J.ROSENGREN,P.J.HARVEY,D.J.CRAIK JRNL TITL STRUCTURAL CHARACTERIZATION OF THE CYCLIC CYSTINE LADDER JRNL TITL 2 MOTIF OF THETA-DEFENSINS. JRNL REF BIOCHEMISTRY V. 51 9718 2012 JRNL REFN ISSN 0006-2960 JRNL PMID 23148585 JRNL DOI 10.1021/BI301363A REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 2.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-KUNSTLEVE, REMARK 3 JIANG,KUSZEWSKI,NILGES,PANNU,READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURES WERE CALCULATED USING THE REMARK 3 SCRIPTS FROM THE RECOORD DATABASE. REMARK 4 REMARK 4 2LZI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 10-OCT-12. REMARK 100 THE RCSB ID CODE IS RCSB103020. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 5.0 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.0 MM HTD-2-1, 90% H2O/10% D2O; REMARK 210 1.0 MM HTD-2-2, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H NOESY; REMARK 210 2D 1H-13C HSQC; 2D DQF-COSY; 2D REMARK 210 1H-1H ECOSY; 2D 1H-15N HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ; 900 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : SPARKY, TOPSPIN 2.1, CYANA 3.0 REMARK 210 METHOD USED : SIMULATED ANNEALING, TORSION REMARK 210 ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 3 ARG A 10 -37.56 -159.96 REMARK 500 4 ARG A 10 -55.03 -137.15 REMARK 500 7 ARG A 10 -39.56 -172.52 REMARK 500 8 ARG A 10 -38.36 -172.64 REMARK 500 11 ARG A 10 -4.34 -149.92 REMARK 500 12 ARG A 10 -39.00 -163.26 REMARK 500 14 ARG A 10 -1.04 -149.82 REMARK 500 15 ARG A 10 -61.72 -143.10 REMARK 500 16 ARG A 10 -0.39 -144.57 REMARK 500 17 ARG A 9 -62.16 -99.53 REMARK 500 19 ARG A 9 -78.76 -78.65 REMARK 500 20 ARG A 9 -76.20 -91.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HVZ RELATED DB: PDB REMARK 900 THREE-DIMENSIONAL STRUCTURE OF RTD-1, A CYCLIC REMARK 900 ANTIMICROBIAL DEFENSIN FROM RHESUS MACAQUE LEUKOCYTES REMARK 900 RELATED ID: 2ATG RELATED DB: PDB REMARK 900 RETROCYCLIN-2: STRUCTURAL ANALYSIS OF A POTENT ANTI-HIV REMARK 900 THETA-DEFENSIN REMARK 900 RELATED ID: 18757 RELATED DB: BMRB DBREF 2LZI A 1 18 PDB 2LZI 2LZI 1 18 SEQRES 1 A 18 GLY ILE CYS ARG CYS ILE CYS GLY ARG ARG ILE CYS ARG SEQRES 2 A 18 CYS ILE CYS GLY ARG SHEET 1 A 2 CYS A 3 CYS A 7 0 SHEET 2 A 2 CYS A 12 CYS A 16 -1 O ARG A 13 N ILE A 6 SSBOND 1 CYS A 3 CYS A 16 1555 1555 2.03 SSBOND 2 CYS A 5 CYS A 14 1555 1555 2.04 SSBOND 3 CYS A 7 CYS A 12 1555 1555 2.03 LINK N GLY A 1 C ARG A 18 1555 1555 1.32 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 107 0 0 0 2 0 0 6 0 0 0 2 END